Health and Wellness Ads on Meta: Evidence, Eligibility and Review

A health or wellness ad needs evidence and an eligibility decision for the actual product, market and intended audience. Changing “cures” to “supports” does not make a claim substantiated or guarantee Meta approval. Evaluate the full message, including images, packaging, testimonials and destination, before producing launch assets.

Classify the product and market first

1. Record whether the offer is a supplement, food, cosmetic, fitness service, device, medicine or another category. Identify the sales jurisdiction and any intended age restrictions.
2. Check the current Meta Advertising Standards for that category and market, plus the restrictions actually shown in the account. Document authorization requirements where applicable.
3. Have a qualified local reviewer assess product sale, claims, labeling and data use. US guidance cited below is not a substitute for another market’s requirements.
4. Keep the status “pending review” until the actual requirements have been assessed. Platform approval itself does not prove medical efficacy or legal compliance.

The US FTC Health Products Compliance Guidance explains the need to substantiate express and implied health claims with appropriate scientific evidence before advertising. Overall consumer impression matters; a process-oriented phrase can still imply a treatment outcome. FDA’s structure/function guidance addresses US supplement labeling distinctions, not automatic Meta ad acceptance.

An evidence packet for one limited promise

Illustrative review request: a supplement seller wants to say “Contains vitamin D.” This is a proposed composition statement, not an assertion about a real product. No dose, test certificate or formulation has been supplied here, so the statement is not approved for publication.

If the seller adds “supports immune function,” treat it as a new health-benefit claim needing its own review. Calling it a hypothesis or adding a small disclaimer does not authorize an unsupported claim in an ad. If the evidence does not support the intended message, narrow the communication to verified product facts or omit the claim.

Review the entire destination

1. Check that the mobile destination refers to the same product, formulation, price and applicable conditions as the ad.
2. Inspect testimonials, FAQ answers, charts and imagery for implied disease or guaranteed-outcome claims, not just the headline.
3. Make material qualifications understandable beside the relevant claim. Check that a shortened crop, caption or translated variant does not remove them.
4. Verify the order or enquiry route and applicable privacy disclosures. Record unresolved questions before approval instead of marking the asset “compliant.”

A lifestyle demonstration can show a real activity, but it cannot replace evidence for a health promise. Do not fabricate a patient story, result, testimonial or clinical-looking chart. No wellness-market size or engagement-rate comparison is needed to make this review procedure useful.

Treat audience and measurement data separately

A first-party list is not unrestricted merely because the advertiser collected it. Inspect consent, permitted advertising use and sensitive inferences before audience activation. Avoid sending health conditions, prescriptions, symptom answers or treatment details in event names, URLs, parameters or uploaded lists. Audit page URLs and checkout fields as well as the nominal event payload.

Check the actual Meta data-source restrictions and available optimization events for this business. Do not rename a sensitive event or conceal context to evade a restriction. A broader audience is a planning option, not a workaround that makes a prohibited product or claim eligible. Special Ad Audiences should not be presented as a current substitute for restricted targeting.

Draft after evidence review, measure after approval

Use the ad review checklist to organize the approved facts and the creative framework for any later bounded test. Evaluate mature qualified outcomes and refund-adjusted economics rather than assuming educational content has a fixed engagement advantage.

NovaStorm can support proposed creative and paused campaign preparation for human review. Medical substantiation, jurisdiction-specific legal review, sensitive-data permission and actual platform approval remain separate decisions; this article does not establish an automated medical or legal approval feature.